MARRTA: Risk matrix in advanced radiotherapy.

Autor: Rot San Juan MJ; Medical Physics department, Hospital Universitario 12 de Octubre, Avda. de Córdoba s/n, 28041 Madrid, Spain. Electronic address: mariajose.rot@salud.madrid.org., Delgado Rodríguez JM; Medical Physics department, Clínica Universidad de Navarra, C. del Marquesado de Sta. Marta 1, 28027 Madrid, Spain., Prieto Martín C; Servicio de Radiofísica y Protección Radiológica H.U. de la Princesa (Madrid) / Departamento de Radiología, Rehabilitación y Fisioterapia, Universidad Complutense de Madrid, Spain., Pérez-Mulas A; Consejo de Seguridad Nuclear, CSN, C. de Pedro Justo Dorado Dellmans, 11, 28040 Madrid, Spain., Sánchez Cayuela C; Genesiscare España, C. Meridiana 20, 29018 Málaga, Spain., Vilanova Ciscar J; Hospital Universitari de la Ribera, km 1 Crta. Corbera, 46600 Alzira, Valencia, Spain., Ramírez Vera ML; Consejo de Seguridad Nuclear, CSN, C. de Pedro Justo Dorado Dellmans, 11, 28040 Madrid, Spain., Ferreras Hernández E; Consejo de Seguridad Nuclear, CSN, C. de Pedro Justo Dorado Dellmans, 11, 28040 Madrid, Spain., Ferrer Albiach C; Fundación Hospital Provincial de Castellón, Gran Vía de Tàrrega Monteblanco 4D, 12006 Castelló de la Plana, Spain., Pardo Masferrer J; Hospital Universitari Son Espases, Carretera de Valldemossa 79 Nord, 07120 Palma, Spain., Ruíz Maqueda S; Hospital Universitario de Fuenlabrada, Cam. Del Molino 2, 28942 Fuenlabrada, Madrid, Spain., Vázquez Camello V; Hospital Universitario de Fuenlabrada, Cam. Del Molino 2, 28942 Fuenlabrada, Madrid, Spain., Suárez Hernández MJ; Hospital Universitario Galdakao-Usansolo, Labeaga Auzoa, 48960 Galdakao, Bizkaia, Spain.

Publikováno v: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) [Phys Med] 2024 Nov; Vol. 127, pp. 104846. Date of Electronic Publication: 2024 Oct 29.

Contributions of throughfall, forest and soil characteristics to near-surface soil water-content variability at the plot scale in a mountainous Mediterranean area

Autor: Molina, A.J., Llorens, P., Garcia-Estringana, P., Moreno de las Heras, M., Cayuela, C., Gallart, F., Latron, J.

Publikováno v: In Science of the Total Environment 10 January 2019 647:1421-1432

Homocysteine and long-term recurrent infarction following an acute coronary syndrome

Autor: Minana G, Gil-Cayuela C, Facila L, Bodi V, Valero E, Mollar A, Marco M, Garcia-Ballester T, Zorio B, Marti-Cervera J, Nunez E, Chorro F, Sanchis J, Nunez J

Publikováno v: Cardiology Journal
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia

BACKGROUND: There are no well-established predictors of recurrent ischemic coronary events after an acute coronary syndrome (ACS). Higher levels of homocysteine have been reported to be associated with an increased atherosclerotic burden. The primary

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d03fd42120cb942875d88ca1cd8d0236
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15251

Lipoprotein(a) and long-term recurrent infarction after an episode of ST-segment elevation acute myocardial infarction

Autor: Minana G, Gil-Cayuela C, Bodi V, de la Espriella R, Valero E, Mollar A, Marco M, Garcia-Ballester T, Zorio B, Fernandez-Cisnal A, Chorro F, Sanchis J, Nunez J

Publikováno v: CORONARY ARTERY DISEASE
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Coronary Artery Disease
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA

BACKGROUND: In established ischemic heart disease, the relationship between lipoprotein(a) and new cardiovascular events showed contradictory results. Our aim was to assess the relationship between lipoprotein(a) and very long-term recurrent myocardi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6e7e713962e9823db5fede1f2cc59c66
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=11962

Value of SERCA2a as a Biomarker for the Identification of Patients with Heart Failure Requiring Circulatory Support.

Autor: Ezzitouny M; Heart Failure and Transplant Unit, Cardiology Department, La Fe University and Polytechnic Hospital, 46026 Valencia, Spain., Roselló-Lletí E; Myocardial Dysfunction and Heart Transplant Group, Health Research Institute La Fe, 46026 Valencia, Spain.; Center for Biomedical Research Network on Cardiovascular Diseases (Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares: CIBERCV), 28029 Madrid, Spain., Portolés M; Myocardial Dysfunction and Heart Transplant Group, Health Research Institute La Fe, 46026 Valencia, Spain.; Center for Biomedical Research Network on Cardiovascular Diseases (Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares: CIBERCV), 28029 Madrid, Spain., Sánchez-Lázaro I; Heart Failure and Transplant Unit, Cardiology Department, La Fe University and Polytechnic Hospital, 46026 Valencia, Spain.; Myocardial Dysfunction and Heart Transplant Group, Health Research Institute La Fe, 46026 Valencia, Spain.; Center for Biomedical Research Network on Cardiovascular Diseases (Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares: CIBERCV), 28029 Madrid, Spain., Arnau-Vives MÁ; Heart Failure and Transplant Unit, Cardiology Department, La Fe University and Polytechnic Hospital, 46026 Valencia, Spain.; Myocardial Dysfunction and Heart Transplant Group, Health Research Institute La Fe, 46026 Valencia, Spain.; Center for Biomedical Research Network on Cardiovascular Diseases (Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares: CIBERCV), 28029 Madrid, Spain., Tarazón E; Myocardial Dysfunction and Heart Transplant Group, Health Research Institute La Fe, 46026 Valencia, Spain.; Center for Biomedical Research Network on Cardiovascular Diseases (Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares: CIBERCV), 28029 Madrid, Spain., Gil-Cayuela C; Myocardial Dysfunction and Heart Transplant Group, Health Research Institute La Fe, 46026 Valencia, Spain., Lozano-Edo S; Heart Failure and Transplant Unit, Cardiology Department, La Fe University and Polytechnic Hospital, 46026 Valencia, Spain., López-Vilella R; Heart Failure and Transplant Unit, Cardiology Department, La Fe University and Polytechnic Hospital, 46026 Valencia, Spain., Almenar-Bonet L; Heart Failure and Transplant Unit, Cardiology Department, La Fe University and Polytechnic Hospital, 46026 Valencia, Spain.; Myocardial Dysfunction and Heart Transplant Group, Health Research Institute La Fe, 46026 Valencia, Spain.; Center for Biomedical Research Network on Cardiovascular Diseases (Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares: CIBERCV), 28029 Madrid, Spain., Martínez-Dolz L; Heart Failure and Transplant Unit, Cardiology Department, La Fe University and Polytechnic Hospital, 46026 Valencia, Spain.; Myocardial Dysfunction and Heart Transplant Group, Health Research Institute La Fe, 46026 Valencia, Spain.; Center for Biomedical Research Network on Cardiovascular Diseases (Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares: CIBERCV), 28029 Madrid, Spain.

Publikováno v: Journal of personalized medicine [J Pers Med] 2021 Oct 31; Vol. 11 (11). Date of Electronic Publication: 2021 Oct 31.